Latest Breaking News On - Paul glasziou - Page 2 : vimarsana.com

'Catastrophic' decision to defund healthcare advice organisation leaves Australians at risk, say experts | Health

The public will be left more susceptible to medical misinformation and harm, doctors and academics say

Professor Paul Glasziou on the long-term impacts of COVID-19

With easing restrictions, vaccinations and low fatality rates, it’s easy to assume the worst of the […]

Jury's in for ivermectin: "No clinical significance."

One of the largest and most rigorous clinical trials to test ivermectin as a COVID-19 treatment has just published its results.

Medical research and funding from big pharma in Australia - researchers fail to declare conflict of interest

A study into the link between money and medical research has found undeclared payments to researchers averaged about $9000 – while some payments from drug companies were up to $97,600.

Medical research and funding from big pharma in Australia - researchers fail to declare conflict of interest

A study into the link between money and medical research has found undeclared payments to researchers averaged about $9000 – while some payments from drug companies were up to $97,600.

Medical research and funding from big pharma in Australia - researchers fail to declare conflict of interest

A study into the link between money and medical research has found undeclared payments to researchers averaged about $9000 – while some payments from drug companies were up to $97,600.

Medical research and funding from big pharma in Australia - researchers fail to declare conflict of interest

A study into the link between money and medical research has found undeclared payments to researchers averaged about $9000 – while some payments from drug companies were up to $97,600.

COVID-19: Omicron now less deadly than flu?

UK population data indicate Omicron carries lower death risk than seasonal flu

Covid-19 NZ: Is it really a good idea to call Omicron 'mild'?

What can be done to improve research integrity?

As the pandemic increases public scrutiny of science, the UK Parliament is holding another inquiry into the long-running issue of reproducibility. Five of its contributors give their views on how sloppy science can be eliminated and trust be more firmly rooted